| 发明名称 | Influenza targets | ||
| 摘要 | The present invention relates to a pharmaceutical composition comprising an inhibitor of influenza virus replication. Yet another aspect is a screening method for identification of new targets for the prevention, alleviation or/and treatment of influenza. | ||
| 申请公布号 | US8933046(B2) | 申请公布日期 | 2015.01.13 |
| 申请号 | US201013518914 | 申请日期 | 2010.12.22 |
| 申请人 | Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V. | 发明人 | Machuy Nikolaus;Karlas Alexander;Meyer Thomas F. |
| 分类号 | C12N15/113;A61K45/06;A61K31/7105;A61K31/711;A61K31/713;A61K31/7088 | 主分类号 | C12N15/113 |
| 代理机构 | Rothwell, Figg, Ernst & Manbeck, P.C. | 代理人 | Rothwell, Figg, Ernst & Manbeck, P.C. |
| 主权项 | 1. A method of treating an influenza virus infection in a patient in need thereof, comprising administering to said patient an effective amount of a TNK2 inhibiting siRNA capable of inhibiting expression of at least one of SEQ ID NO: 957 and SEQ ID NO: 960 in said patient. | ||
| 地址 | Munich DE | ||